Skip to main content

Advertisement

Log in

Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women’s Health Across the Nation

  • Original paper
  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

Purpose

Two case–control studies reported a 50 % decreased breast cancer risk among women who experienced menopausal vasomotor symptoms (VMS), but one cohort study found no association. VMS may be triggered by declining estrogen levels during menopause, whereas elevated estrogen levels have been associated with increased breast cancer risk. VMS may thus be indicative of lower susceptibility to breast cancer.

Methods

We evaluated this relationship in the longitudinal Study of Women’s Health Across the Nation (SWAN), using discrete survival analysis of approximately annual data on VMS and self-reported breast cancer occurrences for up to 13 years of follow-up in 3,098 women who were pre- or early perimenopausal at enrollment.

Results

Over an average 11.4 years of follow-up, 129 incident breast cancer cases were self-reported, and approximately 50 % of participants experienced VMS. Symptomatic women had a reduced risk of breast cancer compared to non-symptomatic women (adjusted HR 0.63, 95 % CI 0.39, 1.00). The association was stronger in the subgroup of women who fully transitioned to postmenopause during follow-up (n = 67 cases, adjusted HR 0.45, 95 % CI 0.26, 0.77).

Conclusion

VMS appeared to be a marker of reduced breast cancer risk. Future research is needed to understand the biology underlying this relationship.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Fei C, DeRoo LA, Sandler DP et al (2013) Menopausal symptoms and the risk of young-onset breast cancer. Eur J Cancer 49:798–804

    Article  PubMed  Google Scholar 

  2. Huang Y, Malone KE, Cushing-Haugen KL et al (2011) Relationship between menopausal symptoms and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 20:379–388

    Article  PubMed  PubMed Central  Google Scholar 

  3. Johanneke van den Berg M, Mishra GD, van der Schouw YT et al (2014) Vasomotor menopausal symptoms are not associated with incidence of breast cancer in a population-based cohort of mid-aged women. Eur J Cancer 50:824–830

    Article  CAS  PubMed  Google Scholar 

  4. Crawford S, Avis N, Kelsey J et al (2004) Is annual measurement of hot flashes sufficiently frequent in perimenopause? [abstract]. Menopause 11:682

    Google Scholar 

  5. Collaborative Group on Hormonal Factors in Breast Cancer (2012) Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies. Lancet Oncol 13:1141–1151

    Article  PubMed Central  Google Scholar 

  6. Hankinson SE (2005) Endogenous hormones and risk of breast cancer in postmenopausal women. Breast Dis 24:3–15

    Article  CAS  PubMed  Google Scholar 

  7. Gompel A, Santen RJ (2012) Hormone therapy and breast cancer risk 10 years after the WHI. Climacteric 15:241–249

    Article  CAS  PubMed  Google Scholar 

  8. Al-Azzawi F, Palacios S (2009) Hormonal changes during menopause. Maturitas 63:135–137

    Article  CAS  PubMed  Google Scholar 

  9. Alexander C, Cochran CJ, Gallicchio L et al (2010) Serum leptin levels, hormone levels, and hot flashes in midlife women. Fertil Steril 94:1037–1043

    Article  CAS  PubMed  Google Scholar 

  10. Freedman RR (2005) Pathophysiology and treatment of menopausal hot flashes. Semin Reprod Med 23:117–125

    Article  PubMed  Google Scholar 

  11. Maclennan AH (2009) Evidence-based review of therapies at the menopause. Int J Evid Based Healthc 7:112–123

    Article  PubMed  Google Scholar 

  12. Sowers M, Crawford S, Sternfeld B et al (2000) SWAN: A multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo R, Kelsey J, Marcus R, Lobo AR (eds) Menopause: biology and pathology. Academic Press, New York, pp 175–188

    Chapter  Google Scholar 

  13. Crandall CJ, Zheng Y, Crawford SL et al (2009) Presence of vasomotor symptoms is associated with lower bone mineral density: a longitudinal analysis. Menopause 16:239–246

    Article  PubMed  PubMed Central  Google Scholar 

  14. Thurston RC, El Khoudary SR, Sutton-Tyrrell K et al (2012) Vasomotor symptoms and insulin resistance in the study of women’s health across the nation. J Clin Endocrinol Metab 97:3487–3494

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA et al (2008) Hot flashes and subclinical cardiovascular disease: findings from the Study of Women’s Health Across the Nation Heart Study. Circulation 118:1234–1240

    Article  PubMed  PubMed Central  Google Scholar 

  16. Gold EB, Colvin A, Avis N et al (2006) Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: study of women’s health across the nation. Am J Public Health 96:1226–1235

    Article  PubMed  PubMed Central  Google Scholar 

  17. Butler LM, Gold EB, Conroy SM et al (2010) Active, but not passive cigarette smoking was inversely associated with mammographic density. Cancer Causes Control 21:301–311

    Article  PubMed  Google Scholar 

  18. Conroy SM, Butler LM, Harvey D et al (2010) Physical activity and change in mammographic density: the Study of Women’s Health Across the Nation. Am J Epidemiol 171:960–968

    Article  PubMed  PubMed Central  Google Scholar 

  19. Block G, Hartman AM, Dresser CM et al (1986) A data-based approach to diet questionnaire design and testing. Am J Epidemiol 124:453–469

    CAS  PubMed  Google Scholar 

  20. Allison PD (2010) Survival analysis using SAS: A practical guide, 2nd edn. SAS Institute, Cary

    Google Scholar 

  21. Avis NE, Crawford SL, McKinlay SM (1997) Psychosocial, behavioral, and health factors related to menopause symptomatology. Womens Health 3:103–120

    CAS  PubMed  Google Scholar 

  22. Freeman EW, Sammel MD, Lin H et al (2005) The role of anxiety and hormonal changes in menopausal hot flashes. Menopause 12:258–266

    Article  PubMed  Google Scholar 

  23. Avis NE, Stellato R, Crawford S et al (2001) Is there a menopausal syndrome? Menopausal status and symptoms across racial/ethnic groups. Soc Sci Med 52:345–356

    Article  CAS  PubMed  Google Scholar 

  24. Grisso JA, Freeman EW, Maurin E et al (1999) Racial differences in menopause information and the experience of hot flashes. J Gen Intern Med 14:98–103

    Article  CAS  PubMed  Google Scholar 

  25. Brown DE, Sievert LL, Morrison LA et al (2009) Do Japanese American women really have fewer hot flashes than European Americans? The Hilo Women’s Health Study. Menopause 16:870–876

    Article  PubMed  PubMed Central  Google Scholar 

  26. Key T, Appleby P, Barnes I et al (2002) Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 94:606–616

    Article  CAS  PubMed  Google Scholar 

  27. Freedman RR, Blacker CM (2002) Estrogen raises the sweating threshold in postmenopausal women with hot flashes. Fertil Steril 77:487–490

    Article  PubMed  Google Scholar 

  28. Berendsen HH (2000) The role of serotonin in hot flushes. Maturitas 36:155–164

    Article  CAS  PubMed  Google Scholar 

  29. Bergmann MM, Calle EE, Mervis CA et al (1998) Validity of self-reported cancers in a prospective cohort study in comparison with data from state cancer registries. Am J Epidemiol 147:556–562

    Article  CAS  PubMed  Google Scholar 

  30. Stavrou E, Vajdic CM, Loxton D et al (2011) The validity of self-reported cancer diagnoses and factors associated with accurate reporting in a cohort of older Australian women. Cancer Epidemiol 35:e75–e80

    Article  PubMed  Google Scholar 

Download references

Financial support

The Study of Women’s Health Across the Nation (SWAN) has grant support from the National Institutes of Health (NIH), DHHS, through the National Institute on Aging (NIA), the National Institute of Nursing Research (NINR), and the NIH Office of Research on Women’s Health (ORWH) (Grants U01NR004061; U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the NIA, NINR, ORWH, or the NIH.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Katherine W. Reeves.

Ethics declarations

Conflict of interest

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hart, V., Sturgeon, S.R., Reich, N. et al. Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women’s Health Across the Nation. Cancer Causes Control 27, 1333–1340 (2016). https://doi.org/10.1007/s10552-016-0811-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10552-016-0811-9

Keywords

Navigation